Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05145998 · ClinicalTrials.gov registry record · NA
Metabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes or Met Syn
A NA study of Type 2 Diabetes Mellitus and Metabolic Syndrome, sponsored by Iowa State University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT05145998: Completed NA study of Type 2 Diabetes Mellitus and Metabolic Syndrome, sponsored by Iowa State University.
NCT05145998 is a NA study of Type 2 Diabetes Mellitus and Metabolic Syndrome that has completed, run by Iowa State University. The registered enrollment target is 19 participants, below the 2,960-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05145998, a NA study of Type 2 Diabetes Mellitus and Metabolic Syndrome, has completed, sponsored by Iowa State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine glycemic response of four different meals containing either whole green peas, whole lentils, powdered green peas, or powdered lentils in comparison to Glucola. Participants are adults with type 2 diabetes mellitus or metabolic syndrome.
Primary Outcome
Venous blood samples were collected via venous catheter. Whole blood samples were analyzed for glucose content and insulin at Quest Diagnostics.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Glucola
- DIETARY_SUPPLEMENT Whole pea meal
- DIETARY_SUPPLEMENT Pea flour meal
- DIETARY_SUPPLEMENT Whole lentils
- DIETARY_SUPPLEMENT Lentil flour
Study Locations (1)
Iowa
- Iowa State University, Food Science and Human Nutrition Department - Ames
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-05-23 |
| Est. Completion | 2020-02-29 |
| Phase | NA |
What the finished NCT05145998 record still lists
NCT05145998 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 2,960-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 5 interventions - of which Glucola is the first listed.
NCT05145998 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT05145998 about?
NCT05145998 is a clinical study titled "Metabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes or Met Syn". The purpose of this study is to determine glycemic response of four different meals containing either whole green peas, whole lentils, powdered green peas, or powdered lentils in comparison to Glucola. Participants are adults with type 2 diabetes mellitus or metabolic syndrome.
What is the current status of trial NCT05145998?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-05-23. Estimated completion is 2020-02-29.
What conditions does trial NCT05145998 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus, Metabolic Syndrome.
What interventions are being tested in trial NCT05145998?
The interventions under investigation include: Glucola (DIETARY_SUPPLEMENT), Whole pea meal (DIETARY_SUPPLEMENT), Pea flour meal (DIETARY_SUPPLEMENT), Whole lentils (DIETARY_SUPPLEMENT), Lentil flour (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05145998?
This trial is sponsored by Iowa State University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05145998 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05145998's enrollment target sits among peer trials
19 115th of 130 higher than 15 of 130 other Type 2 Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
The GRoceries Aimed at Increasing Nutrition Study
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
RECRUITING · NA
-
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
ACTIVE NOT RECRUITING · NA
-
Is the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood Glucose
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI